71 related articles for article (PubMed ID: 33662689)
1. DNA methylation of PTGER4 in peripheral blood plasma helps to distinguish between lung cancer, benign pulmonary nodules and chronic obstructive pulmonary disease patients.
Schotten LM; Darwiche K; Seweryn M; Yildiz V; Kneuertz PJ; Eberhardt WEE; Eisenmann S; Welter S; Sisson BE; Pietrzak M; Wiesweg M; Ploenes T; Hager T; He K; Freitag L; Aigner C; Taube C; Oezkan F
Eur J Cancer; 2021 Apr; 147():142-150. PubMed ID: 33662689
[TBL] [Abstract][Full Text] [Related]
2. A Gene Expression Classifier from Whole Blood Distinguishes Benign from Malignant Lung Nodules Detected by Low-Dose CT.
Kossenkov AV; Qureshi R; Dawany NB; Wickramasinghe J; Liu Q; Majumdar RS; Chang C; Widura S; Kumar T; Horng WH; Konnisto E; Criner G; Tsay JJ; Pass H; Yendamuri S; Vachani A; Bauer T; Nam B; Rom WN; Showe MK; Showe LC
Cancer Res; 2019 Jan; 79(1):263-273. PubMed ID: 30487137
[TBL] [Abstract][Full Text] [Related]
3. A classifier integrating plasma biomarkers and radiological characteristics for distinguishing malignant from benign pulmonary nodules.
Lin Y; Leng Q; Jiang Z; Guarnera MA; Zhou Y; Chen X; Wang H; Zhou W; Cai L; Fang H; Li J; Jin H; Wang L; Yi S; Lu W; Evers D; Fowle CB; Su Y; Jiang F
Int J Cancer; 2017 Sep; 141(6):1240-1248. PubMed ID: 28580707
[TBL] [Abstract][Full Text] [Related]
4. A novel multimodal prediction model based on DNA methylation biomarkers and low-dose computed tomography images for identifying early-stage lung cancer.
Zhang J; Yao H; Lai C; Sun X; Yang X; Li S; Guo Y; Luo J; Wen Z; Tang K
Chin J Cancer Res; 2023 Oct; 35(5):511-525. PubMed ID: 37969955
[TBL] [Abstract][Full Text] [Related]
5. Validation of a multiprotein plasma classifier to identify benign lung nodules.
Vachani A; Pass HI; Rom WN; Midthun DE; Edell ES; Laviolette M; Li XJ; Fong PY; Hunsucker SW; Hayward C; Mazzone PJ; Madtes DK; Miller YE; Walker MG; Shi J; Kearney P; Fang KC; Massion PP
J Thorac Oncol; 2015 Apr; 10(4):629-37. PubMed ID: 25590604
[TBL] [Abstract][Full Text] [Related]
6. Who is at risk of lung nodules on low-dose CT in a Western country? A population-based approach.
Cai J; Vonder M; Du Y; Pelgrim GJ; Rook M; Kramer G; Groen HJM; Vliegenthart R; de Bock GH
Eur Respir J; 2024 Jun; 63(6):. PubMed ID: 38697647
[TBL] [Abstract][Full Text] [Related]
7. Clinical Utility of a Plasma Protein Classifier for Indeterminate Lung Nodules.
Vachani A; Hammoud Z; Springmeyer S; Cohen N; Nguyen D; Williamson C; Starnes S; Hunsucker S; Law S; Li XJ; Porter A; Kearney P
Lung; 2015 Dec; 193(6):1023-7. PubMed ID: 26376647
[TBL] [Abstract][Full Text] [Related]
8. Pulmonary nodules and CT screening: the past, present and future.
Ruparel M; Quaife SL; Navani N; Wardle J; Janes SM; Baldwin DR
Thorax; 2016 Apr; 71(4):367-75. PubMed ID: 26921304
[TBL] [Abstract][Full Text] [Related]
9. Association of the SHOX2 and RASSF1A methylation levels with the pathological evolution of early-stage lung adenocarcinoma.
Zhao J; Lu Y; Ren X; Bian T; Feng J; Sun H; Liu L; She B; Liu Y; Ke H
BMC Cancer; 2024 Jun; 24(1):687. PubMed ID: 38840077
[TBL] [Abstract][Full Text] [Related]
10. Detection of Promoter DNA Methylation in Urine and Plasma Aids the Detection of Non-Small Cell Lung Cancer.
Liu B; Ricarte Filho J; Mallisetty A; Villani C; Kottorou A; Rodgers K; Chen C; Ito T; Holmes K; Gastala N; Valyi-Nagy K; David O; Gaba RC; Ascoli C; Pasquinelli M; Feldman LE; Massad MG; Wang TH; Jusue-Torres I; Benedetti E; Winn RA; Brock MV; Herman JG; Hulbert A
Clin Cancer Res; 2020 Aug; 26(16):4339-4348. PubMed ID: 32430478
[TBL] [Abstract][Full Text] [Related]
11. Tumor-derived Autoantibodies Identify Malignant Pulmonary Nodules.
Lastwika KJ; Kargl J; Zhang Y; Zhu X; Lo E; Shelley D; Ladd JJ; Wu W; Kinahan P; Pipavath SNJ; Randolph TW; Shipley M; Lampe PD; Houghton AM
Am J Respir Crit Care Med; 2019 May; 199(10):1257-1266. PubMed ID: 30422669
[No Abstract] [Full Text] [Related]
12. Detection of the DNA methylation of seven genes contribute to the early diagnosis of lung cancer.
Du C; Tan L; Xiao X; Xin B; Xiong H; Zhang Y; Ke Z; Yin J
J Cancer Res Clin Oncol; 2024 Feb; 150(2):77. PubMed ID: 38315228
[TBL] [Abstract][Full Text] [Related]
13. The combination of SHOX2 and RASSF1A DNA methylation had a diagnostic value in pulmonary nodules and early lung cancer.
Xie B; Dong W; He F; Peng F; Zhang H; Wang W
Oncology; 2024 Jan; ():. PubMed ID: 38262380
[TBL] [Abstract][Full Text] [Related]
14. Multidisciplinary virtual management of pulmonary nodules.
Polanco D; González J; Gracia-Lavedan E; Pinilla L; Plana R; Molina M; Pardina M; Barbé F
Pulmonology; 2024; 30(3):239-246. PubMed ID: 35115280
[TBL] [Abstract][Full Text] [Related]
15. A multiplexed serum biomarker immunoassay panel discriminates clinical lung cancer patients from high-risk individuals found to be cancer-free by CT screening.
Bigbee WL; Gopalakrishnan V; Weissfeld JL; Wilson DO; Dacic S; Lokshin AE; Siegfried JM
J Thorac Oncol; 2012 Apr; 7(4):698-708. PubMed ID: 22425918
[TBL] [Abstract][Full Text] [Related]
16. Utility of peripheral blood macrophage factor Apo10 and TKTL1 as markers in distinguishing malignant from benign lung nodules: a protocol for a prospective cohort study in Southern China.
Xie C; Huang Q; Liu Y
BMJ Open; 2023 Nov; 13(11):e076573. PubMed ID: 37914307
[TBL] [Abstract][Full Text] [Related]
17. Clinical validation of a blood-based classifier for diagnostic evaluation of asymptomatic individuals with pulmonary nodules.
Birse CE; Tomic JL; Pass HI; Rom WN; Lagier RJ
Clin Proteomics; 2017; 14():25. PubMed ID: 28694742
[TBL] [Abstract][Full Text] [Related]
18. No association between global DNA methylation in peripheral blood and lung cancer risk in nonsmoking women: results from a multicenter study in Eastern and Central Europe.
Davis A; Tao MH; Chen J; Scelo G; Bencko V; Fabianova E; Foretova L; Janout V; Lissowska J; Mates D; Mates IN; Rudnai P; Zaridze D; Boffetta P
Eur J Cancer Prev; 2018 Jan; 27(1):1-5. PubMed ID: 27045934
[TBL] [Abstract][Full Text] [Related]
19. Stage at Diagnosis Following Delay to Interval Scans for Indeterminate Nodules in Lung Cancer Screening: An Observational Study Examining the Outcomes of CHEST Expert Panel Recommendations.
Creamer AW; Horst C; Dickson JL; Tisi S; Hall H; Verghese P; Prendecki R; Bhamani A; Khaw CR; McCabe J; Limani T; Gyertson K; Hacker AM; Teague J; Farrelly L; Dawadi S; Hackshaw A; Devaraj A; Nair A; Janes SM;
Chest; 2024 Apr; 165(4):1020-1024. PubMed ID: 37914027
[No Abstract] [Full Text] [Related]
20. S-adenosylmethionine as a biomarker for the early detection of lung cancer.
Greenberg AK; Rimal B; Felner K; Zafar S; Hung J; Eylers E; Phalan B; Zhang M; Goldberg JD; Crawford B; Rom WN; Naidich D; Merali S
Chest; 2007 Oct; 132(4):1247-52. PubMed ID: 17934114
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
